Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc.verified

PRTK

Price:

$2.23

Market Cap:

$127.83M

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co....[Read more]

Industry

Biotechnology

IPO Date

2009-02-03

Stock Exchange

NASDAQ

Ticker

PRTK

The Enterprise Value as of December 2024 (TTM) for Paratek Pharmaceuticals, Inc. (PRTK) is 351.99M

According to Paratek Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 351.99M. This represents a change of 0.43% compared to the average of 350.48M of the last 4 quarters.

Paratek Pharmaceuticals, Inc. (PRTK) Historical Enterprise Value (quarterly & annually)

How has PRTK Enterprise Value performed in the past?

The mean historical Enterprise Value of Paratek Pharmaceuticals, Inc. over the last ten years is 244.78M. The current 351.99M Enterprise Value has changed 14.28% with respect to the historical average. Over the past ten years (40 quarters), PRTK's Enterprise Value was at its highest in in the September 2017 quarter at 713.27M. The Enterprise Value was at its lowest in in the March 2014 quarter at 12.49M.

Quarterly (TTM)
Annual

Average

244.78M

Median

295.29M

Minimum

1.62M

Maximum

423.40M

Paratek Pharmaceuticals, Inc. (PRTK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Paratek Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 12.32%

Maximum Annual Enterprise Value = 423.40M

Minimum Annual Increase = -93.96%

Minimum Annual Enterprise Value = 1.62M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022325.87M-17.03%
2021392.75M-7.24%
2020423.40M44.67%
2019292.67M199.30%
201897.79M-74.78%
2017387.67M30.13%
2016297.91M47.99%
2015201.30M12.32%
20141.62M-93.96%
201326.86M448.55%

Paratek Pharmaceuticals, Inc. (PRTK) Average Enterprise Value

How has PRTK Enterprise Value performed in the past?

The current Enterprise Value of Paratek Pharmaceuticals, Inc. (PRTK) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

380.67M

5-year avg

306.50M

10-year avg

244.78M

Paratek Pharmaceuticals, Inc. (PRTK) Enterprise Value vs. Peers

How is PRTK’s Enterprise Value compared to its peers?

Paratek Pharmaceuticals, Inc.’s Enterprise Value is greater than Selecta Biosciences, Inc. (69.24M), greater than Corvus Pharmaceuticals, Inc. (306.04M), less than Immutep Limited (365.43M), less than Icosavax, Inc. (713.87M), less than Lyra Therapeutics, Inc. (0), greater than Equillium, Inc. (22.89M), greater than HOOKIPA Pharma Inc. (7.02M), greater than LianBio (-38387362.00), greater than Jasper Therapeutics, Inc. (-66141903.00), greater than Affimed N.V. (246.72M), greater than Leap Therapeutics, Inc. (23.07M), greater than Adaptimmune Therapeutics plc (49.44M), greater than Aptose Biosciences Inc. (57.68M), greater than null (24.21M),

Build a custom stock screener for Paratek Pharmaceuticals, Inc. (PRTK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paratek Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Paratek Pharmaceuticals, Inc. (PRTK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Paratek Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Paratek Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Paratek Pharmaceuticals, Inc. (PRTK)?

What is the 3-year average Enterprise Value for Paratek Pharmaceuticals, Inc. (PRTK)?

What is the 5-year average Enterprise Value for Paratek Pharmaceuticals, Inc. (PRTK)?

How does the current Enterprise Value for Paratek Pharmaceuticals, Inc. (PRTK) compare to its historical average?